Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim Wynendaele

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Critical Reviews in Oncology/Hematology|August 5, 2009
Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical OncologyBenoit Beuselinck, Hans Wildiers, Wim Wynendaele, et al.
Transfusion|November 5, 2008
Transfusion-induced serum sicknessVeroniek Saegeman, Wim Wynendaele, Stefan Kerre, et al.
Clinical Genitourinary Cancer|March 30, 2023
Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab: A Retrospective AnalysisLorenz Haaker, Marcella Baldewijns, Liesbeth De Wever, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 13, 2018
Real-world use of granulocyte colony-stimulating factor in ambulatory breast cancer patients: a cross-sectional studyFlorence Van Ryckeghem, Chloë Haverbeke, Wim Wynendaele, et al.
Acta Oncologica (Stockholm, Sweden)|October 29, 2021
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort studySofie Demasure, Isabel Spriet, Philip R Debruyne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCRMohamed Saad Ismail, Wim Wynendaele, Joeri L E Aerts, et al.
Urologic Oncology|May 21, 2020
Bone metastasis is associated with poor prognosis in metastatic papillary renal cell carcinoma patients treated with first agent angiogenesis inhibitorsLorenz Haaker, Loesia Tryssesoone, Inne Renders, et al.
Urologic Oncology|February 7, 2016
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use programCharles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.
Clinical Genitourinary Cancer|March 5, 2017
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?Charles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2018
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter TrialPatrick Neven, Lynn Jongen, Anneleen Lintermans, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|August 5, 2009
Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical OncologyBenoit Beuselinck, Hans Wildiers, Wim Wynendaele, et al.
Transfusion|November 5, 2008
Transfusion-induced serum sicknessVeroniek Saegeman, Wim Wynendaele, Stefan Kerre, et al.
Clinical Genitourinary Cancer|March 30, 2023
Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab: A Retrospective AnalysisLorenz Haaker, Marcella Baldewijns, Liesbeth De Wever, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 13, 2018
Real-world use of granulocyte colony-stimulating factor in ambulatory breast cancer patients: a cross-sectional studyFlorence Van Ryckeghem, Chloë Haverbeke, Wim Wynendaele, et al.
Acta Oncologica (Stockholm, Sweden)|October 29, 2021
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort studySofie Demasure, Isabel Spriet, Philip R Debruyne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCRMohamed Saad Ismail, Wim Wynendaele, Joeri L E Aerts, et al.
Urologic Oncology|May 21, 2020
Bone metastasis is associated with poor prognosis in metastatic papillary renal cell carcinoma patients treated with first agent angiogenesis inhibitorsLorenz Haaker, Loesia Tryssesoone, Inne Renders, et al.
Urologic Oncology|February 7, 2016
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use programCharles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.
Clinical Genitourinary Cancer|March 5, 2017
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?Charles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2018
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter TrialPatrick Neven, Lynn Jongen, Anneleen Lintermans, et al.
Pageof 2